Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry.

MLA

Kapelios, Chris J., et al. “Digoxin Use in Contemporary Heart Failure with Reduced Ejection Fraction: An Analysis from the Swedish Heart Failure Registry.” European Heart Journal. Cardiovascular Pharmacotherapy, vol. 8, no. 8, Dec. 2022, pp. 756–67. EBSCOhost, https://doi.org/10.1093/ehjcvp/pvab079.

APA

Kapelios, C. J., Lund, L. H., Benson, L., Dahlström, U., Rosano, G. M. C., Hauptman, P. J., & Savarese, G. (2022). Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry. European Heart Journal. Cardiovascular Pharmacotherapy, 8(8), 756–767. https://doi.org/10.1093/ehjcvp/pvab079

Chicago

Kapelios, Chris J, Lars H Lund, Lina Benson, Ulf Dahlström, Giuseppe M C Rosano, Paul J Hauptman, and Gianluigi Savarese. 2022. “Digoxin Use in Contemporary Heart Failure with Reduced Ejection Fraction: An Analysis from the Swedish Heart Failure Registry.” European Heart Journal. Cardiovascular Pharmacotherapy 8 (8): 756–67. doi:10.1093/ehjcvp/pvab079.